Interestingly, the disruption of microglia barrier and exacerbated axonal spheroids we observed with Ms4a6d knockout has been a recurring theme related to AD genetic risks, including TREM2 R47H and APOE4 [28, 31, 56]. This evidence concerns the gene APOE and Alzheimer disease.